The Spanish Agency of Medicines and Medical Devices (AEMPS) has published a Checklist to verify the Brexit readiness of companies based in Spain in the sectors…
Beauty and personal care
OEM with European ambition?
Having a commercial brand is not necessary, even as an OEM you can register your products in the CPNP and enjoy the benefits.
Cosmeto-vigilance what to do?
Every cosmetic manufacturer, sooner or later, will be faced with a cosmeto-vigilance case. If there are sales, the undesirable effects will happen. It is therefore crucial to react to every case in an appropriate manner and for the Serious Undesirable Effects (SUE) to inform the relevant authorities – which is a legal obligation.
Personalization of Cosmetic Products
The Obelis team discuss the compliance regulations for personalized cosmetics products on the EU market. How to safely plan for creativity and innovation.
Cosmetic products and cannabis under the EC Cosmetics Regulation 1223/2009
Guidelines for the use and inclusion of cannabis and cannabidiol products within cosmetics on the EU market under EC regulation 1223/2009.
How will cosmetic products be regulated in the UK in case of a no-deal Brexit?
Preparations have begun for cosmetic compliance paths in the UK in the event of a no-deal Brexit. Learn more about new regulatory requirements with Obelis.
The CPNP Notification Process – Step by step
A simple guide to bringing your cosmetics products though the Cosmetics Products Notification Portal for total European Market compliance.
SCCS minutes made public!
Minutes from meetings of the Scientific Committee on Consumer Safety (SCCS) are now public. Read about their discussions and opinions on cosmetic products.
Upcoming event: RMD + CRCC 2019 in Brussels
Obelis invites you to its 4th ERPA Annual Congress on Regulations and Compliance for Cosmetics and EAAR Annual MDR Conference on October 28-29, 2019.
Scientific Opinion on the use of AVO in cosmetic products
SCCS issues scientific opinion on the use of acetylated vetiver oil in EU cosmetic products. Concludes AVO unlikely to cause contact allergies in humans.